Celldex Therapeutics Inc.’s (CLDX) share price has entered into oversold territory with a stochastic value of 13.48. The Zacks Consensus Estimate for 2010 has improved by 11 cents over the past month to a loss of $1.04 per share. Celldex Therapeutics is a Zacks #2 Rank (“Buy”) company.
“CLDX” Free Stock Analysis: Buy? Sell? Hold?
Zacks Investment Research